Concepedia

Blake Morrison

BM

Statistics

Publications

4

Citations

387

H-Index

4

Active since

2005

Affiliations

Institute for Myeloma & Bone Cancer Research(Current)

Oncotherapeutics (United States)

Millennium Engineering and Integration (United States)

Rocky Mountain Cancer Centers

Cedars-Sinai Medical Center

Blake Morrison is an author at Institute for Myeloma & Bone Cancer Research specializing in radiation oncology, hematology, and oncology.

Top concepts

Publications per year

2005–2008

4

Publications

4

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

James R. Berenson, Hank H. Yang, Karen Sadler et al. · Journal of Clinical Oncology · 2006 · 212 citations

A Phase I/II Study of Arsenic Trioxide/Bortezomib/Ascorbic Acid Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma

James R. Berenson, Jeffrey Matous, Regina A. Swift et al. · Clinical Cancer Research · 2007 · 122 citations · Full text

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

James R. Berenson, Hank H. Yang, Robert Vescio et al. · Annals of Hematology · 2008 · 42 citations

, , +7

A Phase I/II Trial Evaluating the Combination of Arsenic Trioxide, Bortezomib and Ascorbic Acid for Patients with Relapsed or Refractory Multiple Myeloma.

James R. Berenson, J. Matouš, Delina Ferretti et al. · Blood · 2005 · 11 citations

Rows per page

1–4 of 4